Filtered By:
Infectious Disease: Hepatitis C
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 11826 results found since Jan 2013.
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
Genotype 4 hepatitis C virus-a review of a diverse genotype
CONCLUSIONS: The availability of safe and effective therapy has created a real opportunity for HCV eradication in line with the goal set by the World Health Organization. An example of a country where this is happening is Egypt, where GT4 accounts for more than 90% of HCV infections. There, broad access to therapy has been effectively supported by population-based screening.PMID:36640687 | DOI:10.1016/j.advms.2022.12.003
Source: Advances in Medical Sciences - January 14, 2023 Category: Biomedical Science Authors: Micha ł Brzdęk Krystyna Dobrowolska Robert Flisiak Dorota Zar ębska-Michaluk Source Type: research
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
Genotype 4 hepatitis C virus-a review of a diverse genotype
CONCLUSIONS: The availability of safe and effective therapy has created a real opportunity for HCV eradication in line with the goal set by the World Health Organization. An example of a country where this is happening is Egypt, where GT4 accounts for more than 90% of HCV infections. There, broad access to therapy has been effectively supported by population-based screening.PMID:36640687 | DOI:10.1016/j.advms.2022.12.003
Source: Advances in Medical Sciences - January 14, 2023 Category: Biomedical Science Authors: Micha ł Brzdęk Krystyna Dobrowolska Robert Flisiak Dorota Zar ębska-Michaluk Source Type: research
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
Genotype 4 hepatitis C virus-a review of a diverse genotype
CONCLUSIONS: The availability of safe and effective therapy has created a real opportunity for HCV eradication in line with the goal set by the World Health Organization. An example of a country where this is happening is Egypt, where GT4 accounts for more than 90% of HCV infections. There, broad access to therapy has been effectively supported by population-based screening.PMID:36640687 | DOI:10.1016/j.advms.2022.12.003
Source: Advances in Medical Sciences - January 14, 2023 Category: Biomedical Science Authors: Micha ł Brzdęk Krystyna Dobrowolska Robert Flisiak Dorota Zar ębska-Michaluk Source Type: research
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
Genotype 4 hepatitis C virus-a review of a diverse genotype
CONCLUSIONS: The availability of safe and effective therapy has created a real opportunity for HCV eradication in line with the goal set by the World Health Organization. An example of a country where this is happening is Egypt, where GT4 accounts for more than 90% of HCV infections. There, broad access to therapy has been effectively supported by population-based screening.PMID:36640687 | DOI:10.1016/j.advms.2022.12.003
Source: Advances in Medical Sciences - January 14, 2023 Category: Biomedical Science Authors: Micha ł Brzdęk Krystyna Dobrowolska Robert Flisiak Dorota Zar ębska-Michaluk Source Type: research
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
Genotype 4 hepatitis C virus-a review of a diverse genotype
CONCLUSIONS: The availability of safe and effective therapy has created a real opportunity for HCV eradication in line with the goal set by the World Health Organization. An example of a country where this is happening is Egypt, where GT4 accounts for more than 90% of HCV infections. There, broad access to therapy has been effectively supported by population-based screening.PMID:36640687 | DOI:10.1016/j.advms.2022.12.003
Source: Advances in Medical Sciences - January 14, 2023 Category: Biomedical Science Authors: Micha ł Brzdęk Krystyna Dobrowolska Robert Flisiak Dorota Zar ębska-Michaluk Source Type: research
Management of Hepatitis C in Children - A New Paradigm
CONCLUSION: With various DAA regimens now being approved for children above three years of age, the treatment of active HCV infection (HCV-RNA positive) in children has become simple. Besides the effectiveness of DAA therapy, public awareness about HCV transmission, better screening, and making the DAAs available at a subsidized price in the public sectors are necessary to eliminate HCV infection in India.PMID:36639971
Source: Indian Pediatrics - January 14, 2023 Category: Pediatrics Authors: Ujjal Poddar D V Umesh Reddy Source Type: research
A Systematic Review on Interferon Alpha-Induced Cognitive Impairment in Hepatitis C Patients
CONCLUSION: In conclusion, we have observed conflicting results regarding the impact of INF-α treatment on the cognitive functioning of patients suffering from HCV. Thus, there is an urgent need for an extensive study to evaluate the exact association between INF-αtherapy and cognitive functioning in HCV patients.PMID:36883269 | DOI:10.2174/1574886317666220428134931
Source: Current Drug Safety - March 8, 2023 Category: Drugs & Pharmacology Authors: Pallavi Kaushik Mohd Ashif Khan Nidhi B Agarwal Aakriti Garg Source Type: research
Association between hepatitis C infection during pregnancy with maternal and neonatal outcomes: a systematic review and meta-analysis
CONCLUSIONS: Mothers with HCV infection had a markedly increased probability of PTB and/or IUGR and/or LBW. In clinical practice, standard care of treatment and proper monitoring are needed for the pregnant population with HCV infection. Our findings may provide useful information for selecting appropriate therapy methods for HCV-positive pregnant women.PMID:37140297 | DOI:10.26355/eurrev_202304_32120
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: G-F Shen C-H Ge W Shen Y-H Liu X-Y Huang Source Type: research
